Loandepot's Q2 loss narrows sharply on home equity push

Loandepot reported a Q2 net loss of $6.6 million, down from $54.9 million in Q1 and $25.3 million a year earlier, citing improved margins from a home equity lending push and a rate-driven servicing gain. Revenue rose 18% to $337.3 million. Q3 guidance: $6.25B to $8.25B volume, 360 to 390 bps margins.

Original reporting
Published Aug 5, 2026, 5:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 5:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Loandepot's Q2 loss narrows sharply on home equity push — source image
Decision brief

The 30-second read

$LOANBullishMed
01

Why it matters

Traders can update models for mortgage origination economics and servicing profitability using the reported Q2 margin rebound, servicing book growth, and the company’s explicit Q3 volume and margin guidance. Activist scrutiny and rising delinquency add downside risk to the earnings trajectory.

02

Market read

Q2 results and Q3 guidance provide a concrete near-term earnings path for a rate-sensitive mortgage lender, with mixed signals from delinquency and recapture.

03

What to watch

Recapture rate slipped to 68% and 60-plus delinquencies rose 30.6% annually, which could pressure future servicing cash flows even if margins on sales improved.

Relevance 7/10Novelty 7/10Timing: pre-market/early trading today after Q2 results and Q3 guidance release

Background

Loandepot is pivoting toward home equity lending and has been loss-making since late 2024, with its stock trading near $1 for months.

Company-level read

Ticker impact

$LOANBullishMedium confidence
Context

Loandepot reported Q2 net loss of $6.6M, narrowed sharply, and guided Q3 volume $6.25B to $8.25B with margins 360 to 390 bps.

Expected impact

Likely supportive for the stock on any follow-through, but tempered by rising 60-plus delinquency and activist pressure.

Evidence & confidence

The article provides fresh, decision-relevant datapoints: quarterly loss narrowing, pull-through gain on sale margin rebound, servicing book growth, and concrete Q3 guidance. Offsetting negatives include slipped recapture rate and higher delinquencies, plus activist calls for strategic review.

Market effects

Reinforces that home-equity mix and servicing economics can partially offset rate-driven headwinds for mortgage lenders/servicers.

Limited, as the disclosure is company-specific with no broader regional macro catalyst.

Low, mortgage-lender fundamentals are mostly US-rate and housing-market driven.

Counterpoint

The headline profitability improvement may be partly driven by servicing valuation dynamics and one-off monetization actions, while credit metrics (delinquencies) are worsening.

Key entities

  • Loandepot

    Mortgage lender and servicer reporting Q2 loss narrowing, home-equity strategy progress, and Q3 guidance.

  • Anthony Hsieh

    Founder and CEO attributing improvement to revenue growth, operating leverage, and home equity mix.

  • David Hayes

    CFO discussing servicing rights monetization and bond maturity management.

  • Randlan Capital

    Activist shareholder urging board to explore a sale and reconsider leadership.

Related articles

$LOANMedAI 8/10

Manhattan Bridge Capital (NASDAQ:LOAN) Share Price Passes Below 200

Manhattan Bridge Capital (NASDAQ:LOAN) shares fell below their 200-day moving average during Wednesday trading, dipping to $4.18 and last trading at $4.23 versus a 200-day average of $4.52. Weiss Ratings downgraded LOAN from “hold (c)” to “hold (c-)” on May 11. The company reported Q1 EPS of $0.11 (vs. $0.12) and revenue of $2.07M (vs. $2.18M), and declared a $0.11 quarterly dividend payable July 15.

$BCPCMedAI 8/10

Balchem Corp (BCPC) Q3 2026 Earnings Call Highlights: Record Revenue, 29th Straight

Balchem Corp (BCPC) reported Q3 2026 record revenue of $291M, up 8.6%, with all segments growing. EBITDA rose 12.4% to $80M, marking 29 straight quarters of growth. The company faces inflationary pressures and seasonality challenges but expects year-over-year growth in Q4. Inventory increased to $177M due to inflation and growth. Clinical trials in Alzheimer's and cardiovascular health show promise, with marketing efforts planned. BCPC's effective tax rate is expected to be 22.5-23%.

$BAHMed

Booz Allen Hamilton Holding Corp (BAH) (Q2 2027) Earnings Call Highlights: Margin Expansion

Booz Allen Hamilton reported a 3.9% revenue decline to $2.8B in Q2 2027, with civil business down 15%. CEO Rozanski expects margins to expand over time due to outcome-based contracting and investments in cyber, including the Vellox suite. Cyber is growing rapidly, and the Ultra acquisition is contributing to defense tech growth. The company faces funding uncertainty and seasonality in the second half.